GEMOPHARM LLC
The lead asset is the monoclonal antibody based on a proprietary therapeutic platform to target CD71 selectively in the tumor microenvironment. Gemopharm’s approach mitigates potential toxicities that may occur from solicitation of non-selective complement dependent cytotoxicity (CDC) activation or addition of a toxin payload. Gemopharm has generated in vivo proof-of-concept data demonstrating substantial efficacy and validating the mechanism of action of the lead candidate. The pilot toxicolo... gy has been completed without any signs of toxicity (no mortalities, clinical signs, or DLTs observed). Gemopharm envisages that its lead candidate can address a high unmet need for effective therapies for relapsed/refractory primary and secondary central nervous system (CNS) and intraocular lymphomas (IOL).
GEMOPHARM LLC
Industry:
Biotechnology Health Care Medical Medical Device Pharmaceutical
Founded:
2016-01-01
Address:
Moscow, Moscow City, Russian Federation
Country:
Russian Federation
Website Url:
http://www.gemopharm.ru
Total Employee:
1+
Status:
Active
Contact:
+79258753977
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx PHP
Similar Organizations
Cellective BioTherapy
Cellective BioTherapy develops novel cellular and monoclonal antibody-based platforms to treat cancer, autoimmunity, and immunodeficiency.
EntomoPharm
EntomoPharm, a biotechnology company, develops insect based screening models for predicting ADMET properties of chemical agents.
Current Employees Featured
Investors List
Primer Capital
Primer Capital investment in Venture Round - Gemopharm LLC
Official Site Inspections
http://www.gemopharm.ru
- Host name: 192.0.78.24
- IP address: 192.0.78.24
- Location: San Francisco United States
- Latitude: 37.7506
- Longitude: -122.4121
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94110
More informations about "Gemopharm LLC"
О компании | ГЕРОФАРМ - geropharm.ru
Компания ГЕРОФАРМ основана в 2001 году. Сегодня ГЕРОФАРМ - крупная и эффективная бизнес ...See details»
Company | GEROPHARM
GEROPHARM offers wonderful conditions for adaptation and development: we were taken to the production site during the training, chiefs of different departments read lectures. The …See details»
Company | GEROPHARM
GEROPHARM was founded in 2001. Today GEROPHARM is a large and efficient business structure, one of the key players at the Russian pharmaceutical market and an expert of the professional community. ... KLIMAX-LUX.RU; …See details»
GEROPHARM
GEROPHARM Launched a Training Programme for Doctors from Venezuela. 10.11.2024. Production of Insulins under the GEROPHARM Technology Will Be Launched in Venezuela in …See details»
GEMOPHARM
Nov 24, 2017 Our lead candidate (KB-121) is a humanized antibody belonging to the IgG1 isotype. KB-121 binds to the extracellular domain of the transferrin receptor of the first type …See details»
GEROPHARM
Компания ГЕРОФАРМ основана в 2001 году. Сегодня ГЕРОФАРМ - крупная и эффективная бизнес ...See details»
Портфель компании | ГЕРОФАРМ - geropharm.ru
Портфель компании. ГЕРОФАРМ контролирует полный жизненный цикл препаратов: glp, gcp, gvp, gmp, gdpSee details»
Герофарм — Википедия
Кортексин / неврология; Кортексин для детей / неврология; Леветинол / Неврология; Мемантинол / Неврология (группа Мемантин)See details»
Geropharm - Crunchbase Company Profile & Funding
Contact Email [email protected]; Phone Number +7 812-703-79-75; Geropharm is a biotechnological company that provides development, production, and investment for the …See details»
GEROPHARM - LinkedIn
GEROPHARM is one of the 20 leading Russian manufacturers of pharmaceutical preparations. The company has modern industrial sites, where production is carried out on the principle of …See details»
Portfolio | GEROPHARM
GEROPHARM pays considerable attention to the regulation of drug safety. The company has the pharmacovigilance system which functions in accordance with the requirements of Russian …See details»
Geropharm Company Profile 2024: Valuation, Funding & Investors
Geropharm General Information Description. Manufacturer of biotechnological products based in Saint Petersburg, Russia. The company engages in the development and production of insulin …See details»
GEROPHARM Company Profile - Office Locations, Competitors
GEROPHARM is a pharmaceutical company developing gene-engineering human insulins. It specializes in restoring brain function and the treatment of diabetes. Type Private Status …See details»
Geropharm - Made in Russia
The company "GEROPHARM" is engaged in the creation of modern pharmaceutical infrastructure, development and production of socially important medicines. The whole line of …See details»
Manufacture | GEROPHARM
A leading full-cycle producer of gene-engineering human insulin – from synthesis of a substance to finished dosage form. The plant can cover 30% of Russian needs in insulinSee details»
Development and production - geropharm.ru
Opening of GEROPHARM plant in Obolensk, Moscow RegionLaunch of Levetinol®, Memantinol® 2013 The plant in Obolenskis able to provide 30% of the Russian needs in insulin 2015 Taking …See details»
Russia Issued a Compulsory License to Produce Analogues of …
Dec 29, 2023 Geropharm has obtained a compulsory license for the diabetes drug Semavik, which is an Ozempic analogue. The company will be able to produce it for a year without the …See details»
Company's news | GEROPHARM
Full line of GEROPHARM rapid-acting insulins for medicinal safety of patients 5.04.2024 A drug for obesity treatment, analogue of Wegovy, will be launched in RussiaSee details»
GEROPHARM Relaunched Ozempic® in Russia, Under the Name …
Russian company GEROPHARM made a decision to launch its own, domestically produced, analogue of Ozempic® — Semavic® — in order to fully cover the need of the healthcare …See details»